30 results on '"Zachée P"'
Search Results
2. Erythrocyte deformability (ED) and oxidative sensitivity (OS) in haemodialysis patients (HD)
3. Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study
4. Myelofibrosis patients in Belgium: disease characteristics
5. JAK2 V617F MUTATION AND PRV-1 OVEREXPRESSION: RELEVANCE IN THE DIAGNOSIS OF POLYCYTHAEMIA VERA AND ESSENTIAL THROMBOCYTHAEMIA
6. A Multicentre Phase II Study of the Aminopeptidase Inhibitor, CHR- 2797, in the Treatment of Elderly and/or Previously Treated patients with Acute Myeloid Leukemia.
7. Palifermin Treatment in Patients Receiving High Dose Melphalan or BEAM Prior to Autologous Peripheral Blood Stem-Cell Transplantation.
8. High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study
9. Pseudo-Pulmonary Embolism as a Sign of Acute Heparin-Induced Thrombocytopenia in Hemodialysis Patients: Safety of Resuming Heparin after Disappearance of HIT Antibodies
10. Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia.
11. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
12. Pasteurella multocida as a Rare Cause of Peritonitis in Peritoneal Dialysis
13. TPC3: COST OF AML TREATMENT IN BELGIUM: RESULTS OF A RANDOMIZED TRIAL WITH AND WITHOUT FILGRASTIM USE
14. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis
15. A single course of remission reinduction chemotherapy for acute myelogenous leukemia relapsing after allogeneic bone marrow transplantation is complicated by graft-versus-host disease and followed by sustained complete remission
16. Safety of Combining Ticlopidine with Nadroparin in the Routine Treatment of Chronic Hemodialysis Patients
17. Risks of rhG-CSF treatment in drug-induced agranulocytosis
18. Reduced Glutathione for the Treatment of Anemia during Hemodialysis: A Preliminary Communication
19. Hematologic aspects of end-stage renal failure
20. Neutrophil Adhesion Molecules in Chronic Hemodialysis Patients
21. CONSTITUTION AND BEHAVIOUR OF THE SPHEROCYTE MEMBRANE
22. ADVERSE ROLE OF THE SPLEEN IN HEREDITARY SPHEROCYTOSIS: EVIDENCE BY THE USE OF THE ATOMIC FORCE MICROSCOPE
23. Effect of Recombinant Human Erythropoietin on Reticulocyte Age in Hemodialysis Patients
24. Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: A clinical and erythrokinetic assessment
25. Erythropoietin, aluminium, and anaemia in patients on haemodialysis
26. Red Blood Cell Function and β2 Microglobulin Kinetics during Cuprophan Hemodialysis: A Hypothesis
27. Serum amylase and lipase values in acute renal failure.
28. ERYTHROCYTES(RBC) AS SUICIDAL ENDOGENOUS SCAVENGERS IN IMMUNE TRIGGERED GRANULOCYTE(PMN)MEDIATED VASCULAR DAMAGE
29. Continuous Ambulatory Peritoneal Dialysis (CAPD) in a Patient with Glucose-6-Phosphatase Deficiency
30. PYRUVATE KINASE DEFICIENCY AND DELAYED CLINICAL RESPONSE TO RECOMBINANT HUMAN ERYTHROPOIETIN TREATMENT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.